Delivery Order SPM20003D1666-LQ93
Award Date 12/28/07
Potential Completion Date 12/28/07
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Sacramento, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for Perjeta 420 mg/14 ml vials with a ceiling value of $49,058.10 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract vehicle for pharmaceutical supply to Department of Defense healthcare facilities worldwide. The parent contract, awarded to DMS Pharmaceutical Group on November 13, 2025,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 9, 2026, for Perjeta 420 mg/14 mL vials, with a ceiling value of $49,058.10 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support...
- The Defense Logistics Agency issued a $16,000 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for Prolastin C 1,000 mg/20 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. Place of performance is Park...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, with a ceiling value of $22,054.20 for supply of VABYSMO 6 MG/0.05 ML syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge,...
- The Defense Logistics Agency issued a $20,358.98 delivery order to DMS Pharmaceutical Group Inc. on April 21, 2026, for 3,750 units of ONCASPAR 5 ml vial under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The order has a firm...
- The Defense Logistics Agency issued a $3,492.12 delivery order to DMS Pharmaceutical Group Inc. on April 2, 2026, for Avastin 100 mg/4 mL vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a $6,948.18 delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, for Infuvite Adult Vial 10ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, with a ceiling value of $18,404.70 for Photrexa cross-linking kit 6ml, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is a DLA-administered pharmaceutical supply contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, with a ceiling value of $18,404.70, for Photrexa cross-linking kit (6ml) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge, IL. The order...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,098.72 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 3, 2026, for tobramycin ophthalmic product under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...